Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1994 1
1995 3
1996 1
1997 2
1998 4
1999 4
2000 7
2001 5
2002 9
2003 12
2004 14
2005 20
2006 17
2007 19
2008 6
2009 8
2010 5
2011 5
2012 10
2013 13
2014 10
2015 10
2016 3
2017 6
2018 10
2019 2
2020 5
2021 9
2022 9
2023 8
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

220 results

Results by year

Filters applied: . Clear all
Page 1
Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial.
Bennouna J, Sastre J, Arnold D, Österlund P, Greil R, Van Cutsem E, von Moos R, Viéitez JM, Bouché O, Borg C, Steffens CC, Alonso-Orduña V, Schlichting C, Reyes-Rivera I, Bendahmane B, André T, Kubicka S; ML18147 Study Investigators. Bennouna J, et al. Lancet Oncol. 2013 Jan;14(1):29-37. doi: 10.1016/S1470-2045(12)70477-1. Epub 2012 Nov 16. Lancet Oncol. 2013. PMID: 23168366 Clinical Trial.
Control charts for measurement error models.
Golosnoy V, Hildebrandt B, Köhler S, Schmid W, Seifert MI. Golosnoy V, et al. Among authors: hildebrandt b. Adv Stat Anal. 2022 Oct 5:1-20. doi: 10.1007/s10182-022-00462-8. Online ahead of print. Adv Stat Anal. 2022. PMID: 36213519 Free PMC article.
Improving the accuracy of prognostication in chronic myelomonocytic leukemia.
Kaivers J, Schuler E, Hildebrandt B, Betz B, Rautenberg C, Haas R, Kobbe G, Gattermann N, Germing U. Kaivers J, et al. Among authors: hildebrandt b. Expert Rev Anticancer Ther. 2020 Aug;20(8):703-714. doi: 10.1080/14737140.2020.1796644. Epub 2020 Aug 6. Expert Rev Anticancer Ther. 2020. PMID: 32700646 Review.
Acute basophilic leukemia.
Giagounidis AA, Hildebrandt B, Heinsch M, Germing U, Aivado M, Aul C. Giagounidis AA, et al. Among authors: hildebrandt b. Eur J Haematol. 2001 Aug;67(2):72-6. doi: 10.1034/j.1600-0609.2001.t01-1-00487.x. Eur J Haematol. 2001. PMID: 11722593
Hyperthermia in combined treatment of cancer.
Wust P, Hildebrandt B, Sreenivasa G, Rau B, Gellermann J, Riess H, Felix R, Schlag PM. Wust P, et al. Among authors: hildebrandt b. Lancet Oncol. 2002 Aug;3(8):487-97. doi: 10.1016/s1470-2045(02)00818-5. Lancet Oncol. 2002. PMID: 12147435 Review.
Biallelic variants in CRIPT cause a Rothmund-Thomson-like syndrome with increased cellular senescence.
Averdunk L, Huetzen MA, Moreno-Andrés D, Kalb R, McKee S, Hsieh TC, Seibt A, Schouwink M, Lalani S, Faqeih EA, Brunet T, Boor P, Neveling K, Hoischen A, Hildebrandt B, Graf E, Lu L, Jin W, Schaper J, Omer JA, Demaret T, Fleischer N, Schindler D, Krawitz P, Mayatepek E, Wieczorek D, Wang LL, Antonin W, Jachimowicz RD, von Felbert V, Distelmaier F. Averdunk L, et al. Among authors: hildebrandt b. Genet Med. 2023 Jul;25(7):100836. doi: 10.1016/j.gim.2023.100836. Epub 2023 Mar 31. Genet Med. 2023. PMID: 37013901 Free article.
The cellular and molecular basis of hyperthermia.
Hildebrandt B, Wust P, Ahlers O, Dieing A, Sreenivasa G, Kerner T, Felix R, Riess H. Hildebrandt B, et al. Crit Rev Oncol Hematol. 2002 Jul;43(1):33-56. doi: 10.1016/s1040-8428(01)00179-2. Crit Rev Oncol Hematol. 2002. PMID: 12098606 Review.
The effect of induced hyperthermia on the immune system.
Dieing A, Ahlers O, Hildebrandt B, Kerner T, Tamm I, Possinger K, Wust P. Dieing A, et al. Among authors: hildebrandt b. Prog Brain Res. 2007;162:137-52. doi: 10.1016/S0079-6123(06)62008-6. Prog Brain Res. 2007. PMID: 17645918 Review.
220 results